MedTrace Logo

Impact of Antiretroviral Therapy on Cardiac Biomarkers

NCT00641888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-07-11

No results posted yet for this study

Summary

Cardiovascular risk appears to be linked to some degree with inflammation. HIV medications have been linked with cardiovascular risk. In this study we will be measuring levels of chemicals in the body associated with inflammation before and after starting HIV medications in patients with HIV. We hope to understand what happens to these chemicals once a patient with HIV is started on these medications to understand their role in cardiovascular risk.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • California HIV/AIDS Research Program

    collaborator OTHER

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Archana Maniar, MD · University of California, Davis

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641888 on ClinicalTrials.gov